ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
3,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
3,2,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
3,3,Sexually inappropriate behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
4,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
4,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
4,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
4,4,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
5,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
5,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
6,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
7,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
7,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
9,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
10,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
11,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
12,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
12,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
12,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
12,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
12,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
13,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
13,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
15,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
19,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
21,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
22,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
22,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
23,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
24,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
24,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
24,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
26,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
28,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
29,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
29,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
29,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,1,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
31,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
31,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,4,Nodular rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
32,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
32,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
32,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
33,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
33,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
34,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
35,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
35,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
35,5,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
35,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
37,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
37,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
37,3,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
37,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
37,6,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
37,7,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
37,8,Self-destructive behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
37,9,Sexually inappropriate behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
37,10,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
38,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
38,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
39,1,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
40,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
42,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
43,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
44,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
44,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
44,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
44,4,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
44,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
45,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
45,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
46,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
47,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
48,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
48,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
49,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
49,2,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
49,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
50,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
50,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
50,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
51,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
51,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
52,1,Heat exhaustion,Heat injuries (excl thermal burns),Injuries by physical agents,Inj&P,N
52,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
52,3,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
53,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
54,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
55,1,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
56,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
56,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
56,3,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
56,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
56,6,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
56,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
56,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
56,9,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,10,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
56,11,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
56,12,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
56,13,Polydipsia psychogenic,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
56,14,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
57,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
57,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
58,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
58,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
58,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
58,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
58,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
58,7,Reduced facial expression,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
58,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
58,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
58,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
59,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
59,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
59,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
60,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
61,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
62,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
63,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
64,1,Activation syndrome,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
64,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
64,3,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,4,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
64,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
64,6,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
64,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
65,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Activation syndrome,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
66,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
66,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,4,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
66,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
67,1,Sleep sex,Parasomnias,Sleep disorders and disturbances,Psych,N
67,2,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
68,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
69,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
69,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
70,1,Sleep sex,Parasomnias,Sleep disorders and disturbances,Psych,N
70,2,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
71,1,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
71,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
72,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
74,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
74,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
74,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
74,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
74,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
74,6,Psychiatric decompensation,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
74,7,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
75,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
76,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
76,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
77,1,Migraine,Migraine headaches,Headaches,Nerv,N
77,2,Migraine,Migraine headaches,Headaches,Nerv,N
78,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
78,2,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
79,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
81,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
82,2,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
83,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
84,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
85,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
85,3,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
85,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
86,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
87,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
87,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
88,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
89,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
89,2,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
90,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
91,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
92,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
93,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
93,2,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
94,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
94,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
95,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
95,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
96,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
96,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
97,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
98,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
99,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
100,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
100,2,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
101,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
101,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
102,1,Sleep paralysis,Abnormal sleep-related events,Sleep disturbances (incl subtypes),Nerv,N
102,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
103,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,2,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
104,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
105,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
105,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
105,3,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
105,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
105,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
105,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
105,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
105,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
105,9,Obsessive-compulsive symptom,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
105,10,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
106,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
107,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
107,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
107,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
107,4,Soliloquy,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
108,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
108,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
109,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
109,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
110,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
110,3,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
111,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
111,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
111,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
112,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
112,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
113,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
114,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
115,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
115,2,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
116,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
117,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
117,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
118,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
118,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
119,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
120,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
121,1,Headache,Headaches NEC,Headaches,Nerv,N
121,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
121,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
122,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
122,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
122,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
122,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
122,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
123,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
123,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
124,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
125,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
125,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
127,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
127,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
127,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
128,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
129,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
130,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
131,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
132,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
133,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
134,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
134,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
135,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
135,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
136,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
137,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
138,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,Y
139,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
139,3,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
139,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
140,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
140,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
140,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
141,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
142,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
143,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
144,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
144,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
145,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
145,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
146,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
146,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
146,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
146,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
147,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
148,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
149,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
149,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
149,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
149,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
149,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
149,6,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
149,7,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
149,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
149,9,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
149,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
150,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
150,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
150,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
150,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
150,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
151,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
151,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
151,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
152,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
152,2,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
152,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
152,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
153,1,Excessive eye blinking,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
153,2,Head titubation,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
153,3,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
154,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
154,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
154,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
155,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
155,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
155,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
156,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
156,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
156,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
157,1,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
158,1,Convulsive threshold lowered,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
158,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
159,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
159,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
160,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
160,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
160,3,Protrusion tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
160,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
160,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
160,6,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
161,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
161,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
161,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
162,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
162,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
163,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
164,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
164,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
165,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
165,2,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
165,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
166,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
167,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
168,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
168,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
169,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
170,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
170,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
171,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
171,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
171,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
171,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
172,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
173,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
173,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
173,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
173,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
173,7,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
173,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
173,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
173,10,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
173,11,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
173,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
173,13,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
174,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
174,2,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
174,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
174,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
175,2,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
175,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
175,4,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
175,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
175,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
175,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
175,8,Suspiciousness,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
176,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
176,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
176,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
176,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
177,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
177,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
177,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
177,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
178,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
178,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
179,1,Grimacing,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
179,2,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
179,3,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
180,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
180,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
180,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
180,4,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
181,1,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
182,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
182,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
184,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
184,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
185,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
185,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
185,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
185,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
187,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
188,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
188,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
189,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
190,1,Painful erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
191,1,Erection increased,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
191,2,Painful erection,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
192,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
192,2,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
193,1,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
194,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
194,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,3,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
194,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
194,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
195,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
195,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
195,3,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
196,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
197,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
198,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
198,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
199,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
199,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
199,3,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
200,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
200,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
201,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
201,2,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
201,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
201,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
202,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
202,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
203,1,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
204,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
205,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
206,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
206,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
206,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
206,4,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
206,5,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
206,6,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
206,7,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
206,8,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
206,9,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
206,10,Ketonuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
206,11,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
206,12,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
206,13,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
206,14,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
206,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
206,16,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
206,17,Starvation ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
206,18,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
206,19,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
206,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
207,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
208,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
209,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
209,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
209,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
209,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
209,5,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
209,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
209,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
210,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
211,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
211,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
211,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
211,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
211,5,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
211,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
211,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
212,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
212,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
212,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
212,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
212,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
212,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
213,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
214,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
214,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
215,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
215,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
216,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
217,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
217,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
217,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,5,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
218,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
219,1,Headache,Headaches NEC,Headaches,Nerv,N
219,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
219,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
219,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
219,5,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
220,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
220,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
220,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
222,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
223,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
224,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
225,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
225,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
225,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
225,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
225,5,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
226,1,Eosinophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
226,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
226,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
226,6,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
226,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
227,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
228,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
229,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
230,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
232,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
233,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
234,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
235,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
236,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
237,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
237,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
237,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
238,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
